V. Ashutosh Rao

4.3k citations

70 papers · 3.4k indexed · 2 hit papers · h-index 27

Molecular Biology top 5%
Oncology top 2%
Cancer Research top 5%
Cardiology and Cardiovascular Medicine top 10%
Cell Biology top 5%

Co-authors: Yves Pommier Baikuntha Aryal Adel K. El‐Naggar Lisa Caldwell Tomoo Iwakuma John M. Parant Yasmine A. Valentin-Vega Louise C. Strong
Topics: DNA Repair Mechanisms (12 papers)Protein purification and stability (10 papers)Cancer therapeutics and mechanisms (10 papers)
Cited by: Oncology Cancer Research Molecular Biology
Journals: Cell Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States United Kingdom India

In The Last Decade

V. Ashutosh Rao

67 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

2004 822 citations V. Ashutosh Rao et al. profile →
Trends in the approval of cancer therapies by the FDA in the twenty-first century

2023 155 citations V. Ashutosh Rao, Julia A. Beaver et al. profile →

Peers

Countries citing papers authored by V. Ashutosh Rao

Since Specialization

Citations

This map shows the geographic impact of V. Ashutosh Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Ashutosh Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Ashutosh Rao more than expected).

Fields of papers citing papers by V. Ashutosh Rao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Ashutosh Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Ashutosh Rao. The network helps show where V. Ashutosh Rao may publish in the future.

Co-authorship network of co-authors of V. Ashutosh Rao

This figure shows the co-authorship network connecting the top 25 collaborators of V. Ashutosh Rao. A scholar is included among the top collaborators of V. Ashutosh Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Ashutosh Rao. V. Ashutosh Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metal-induced oxidative stress and human plasma protein oxidation after SARS-CoV-2 infection 2023 ·Scientific Reports ·Baikuntha Aryal,(unknown),(unknown),(unknown),Sarah L. J. Michel,V. Ashutosh Rao	11
2	Protocol to Assess the Biological Activity of Insulin Glargine, Insulin Lispro, and Insulin Aspart In Vitro 2023 ·Methods and Protocols ·(unknown),(unknown),(unknown),V. Ashutosh Rao,Carole Sourbier	0
3	SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins 2022 ·PLoS ONE ·(unknown),Thomas Biel,Uriel Ortega‐Rodriguez,(unknown),(unknown),(unknown),Hang Xie,Cyrus Agarabi,V. Ashutosh Rao,Tongzhong Ju	5
4	In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines 2022 ·PLoS ONE ·Francesca Mascia,Ilya Mazo,(unknown),Konstantinos Karagiannis,Wells W. Wu,Rong‐Fong Shen,Julia A. Beaver,V. Ashutosh Rao	11
5	Gamma-tocotrienol, a radiation countermeasure, reverses proteomic changes in serum following total-body gamma irradiation in mice 2022 ·Scientific Reports ·(unknown),Oluseyi O. Fatanmi,Stephen Y. Wise,V. Ashutosh Rao,Vijay K. Singh	25
6	A Comprehensive Scientific Survey of Excipients Used in Currently Marketed, Therapeutic Biological Drug Products 2020 ·Pharmaceutical Research ·V. Ashutosh Rao,(unknown),(unknown),(unknown),(unknown)	37
7	Acute total body ionizing gamma radiation induces long-term adverse effects and immediate changes in cardiac protein oxidative carbonylation in the rat 2020 ·PLoS ONE ·(unknown),Dmitry Kryndushkin,Baikuntha Aryal,Yanira González,Leena Chehab,Jennifer S. Dickey,V. Ashutosh Rao	9
8	Report of a TREAT-NMD/World Duchenne Organisation Meeting on Dystrophin Quantification Methodology 2019 ·Journal of Neuromuscular Diseases ·Annemieke Aartsma‐Rus,(unknown),Jennifer E. Morgan,(unknown),Hendrik Neubert,Jane Owens,Michael Binks,Marisol Montolio,Rahul Phadke,Nicole A. Datson,J. van Deutekom,Glenn E. Morris,V. Ashutosh Rao,Eric P. Hoffman,Francesco Muntoni,Virginia Arechavala‐Gomeza	44
9	Human Defensin-5 Blocks Ethanol and Colitis-Induced Dysbiosis, Tight Junction Disruption and Inflammation in Mouse Intestine 2018 ·Scientific Reports ·Pradeep K. Shukla,Avtar S. Meena,V. Ashutosh Rao,(unknown),Louisa Balázs,Radhakrishna Rao	41
10	Complex Nature of Protein Carbonylation Specificity After Metal-Catalyzed Oxidation 2017 ·Pharmaceutical Research ·Dmitry Kryndushkin,Wells W. Wu,(unknown),Michael A. Norcross,Rong‐Fong Shen,V. Ashutosh Rao	16
11	Deficiency in Cardiolipin Reduces Doxorubicin-Induced Oxidative Stress and Mitochondrial Damage in Human B-Lymphocytes 2016 ·PLoS ONE ·Baikuntha Aryal,V. Ashutosh Rao	50
12	Reproductive hormone levels and differential mitochondria-related oxidative gene expression as potential mechanisms for gender differences in cardiosensitivity to Doxorubicin in tumor-bearing spontaneously hypertensive rats 2015 ·Cancer Chemotherapy and Pharmacology ·Yanira González,Kaytee Pokrzywinski,(unknown),Steven Mog,Baikuntha Aryal,Leena Chehab,Vikrant Vijay,Carrie L. Moland,Varsha G. Desai,Jennifer S. Dickey,V. Ashutosh Rao	23
13	Mitochondrial Topoisomerase I (Top1mt) Is a Novel Limiting Factor of Doxorubicin Cardiotoxicity 2014 ·Clinical Cancer Research ·Salim Khiati,Ilaria Dalla Rosa,Carole Sourbier,Xuefei Ma,V. Ashutosh Rao,Leonard Μ. Neckers,Hongliang Zhang,Yves Pommier	101
14	Mito-Tempol and Dexrazoxane Exhibit Cardioprotective and Chemotherapeutic Effects through Specific Protein Oxidation and Autophagy in a Syngeneic Breast Tumor Preclinical Model 2013 ·PLoS ONE ·Jennifer S. Dickey,Yanira González,Baikuntha Aryal,Steven Mog,Asako Nakamura,Christophe E. Redon,Ulrich Baxa,(unknown),Gang Cheng,Jacek Zielonka,Palak R. Parekh,Karen Mason,Joy Joseph,Balaraman Kalyanaraman,William Bonner,Eugene H. Herman,Emily Shacter,V. Ashutosh Rao	52
15	The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats 2011 ·Cancer Chemotherapy and Pharmacology ·V. Ashutosh Rao,Jun Zhang,Sarah R. Klein,Parvaneh Espandiari,Alan Knapton,Jennifer S. Dickey,Eugene H. Herman,Emily Shacter	21
16	The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase IIα in Breast Cancer Cells 2009 ·Cancer Research ·V. Ashutosh Rao,Sarah R. Klein,Keli Agama,Eriko Toyoda,Noritaka Adachi,Yves Pommier,Emily Shacter	139
17	Endogenous γ-H2AX-ATM-Chk2 Checkpoint Activation in Bloom's Syndrome Helicase–Deficient Cells Is Related to DNA Replication Arrested Forks 2007 ·Molecular Cancer Research ·V. Ashutosh Rao,Chiara Conti,Josée Guirouilh‐Barbat,Asako Nakamura,Ze‐Hong Miao,(unknown),Barbara Saccà,Ian D. Hickson,Aaron Bensimon,Yves Pommier	76
18	Batracylin (NSC 320846), a Dual Inhibitor of DNA Topoisomerases I and II Induces Histone γ-H2AX as a Biomarker of DNA Damage 2007 ·Cancer Research ·V. Ashutosh Rao,Keli Agama,Susan L. Holbeck,Yves Pommier	69
19	Activation of a p53-mediated apoptotic pathway in quiescent lymphocytes after the inhibition of DNA repair by fludarabine. 2003 ·PubMed ·V. Ashutosh Rao,William Plunkett	26
20	Mechanisms of apoptosis induction by nucleoside analogs 2003 ·Oncogene ·Deepa Sampath,V. Ashutosh Rao,William Plunkett	165

About V. Ashutosh Rao

V. Ashutosh Rao is a scholar working on Toxicology, Molecular Biology and Cancer Research, having authored 70 papers that have together received 3.4k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (12 papers), Protein purification and stability (10 papers) and Cancer therapeutics and mechanisms (10 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (523 citations) and Molecular Biology (2.4k citations). V. Ashutosh Rao has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Yves Pommier, Baikuntha Aryal, Adel K. El‐Naggar, Lisa Caldwell, Tomoo Iwakuma, John M. Parant, Yasmine A. Valentin-Vega, Louise C. Strong, Tamara Terzian and Geng Liu. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact